European pharmaceutical group warns that EU policymakers’ efforts to address issues fall “well short”
Europe’s share of the global investment in pharmaceutical R&D has shrunk, putting the bloc even further behind the US, an industry group has warned.
Pharmaceutical R&D expenditure in the US exceeded that in Europe by more than €20 billion ($20bn) in 2020, and the gap between the two has widened from just €2bn 20 years ago, the report from the European Association of Pharmaceutical Industries and Associations (Efpia) notes.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.